Rare Ebola outbreak poses low risk globally but worries mount about its spread in Congo

The World Health Organization (WHO) declared a rare Bundibugyo Ebola virus outbreak in Congo and Uganda a public health emergency, with 51 confirmed cases and 139 suspected deaths, while warning of underprepared healthcare systems and rising prices for protective supplies in affected regions. Experts anticipate the outbreak could last at least two months, with no approved vaccine or medicine available, and border areas like Mongbwalu remaining vulnerable due to ongoing gold mining and inadequate isolation facilities.
The World Health Organization (WHO) declared a rare Ebola outbreak in Congo and Uganda a public health emergency on Wednesday, citing the rapid spread of the Bundibugyo virus. The outbreak, with 51 confirmed cases and 139 suspected deaths, has overwhelmed local hospitals in Congo’s Ituri and North Kivu provinces, as well as two cases in Uganda. WHO Director-General Tedros Adhanom Ghebreyesus warned the true scale is likely larger, with numbers expected to rise further. In Bunia, where the first death was recorded, residents reported shortages of face masks and disinfectants, with prices surging from 2,500 to 10,000 Congolese francs. Schools and churches remain open, but aid groups like Doctors Without Borders described hospitals lacking isolation wards, with one facility reporting no space for suspected cases. Trish Newport, an emergency program manager, said health centers in Bunia are overwhelmed, with no capacity to handle confirmed Ebola patients. Mongbwalu, the outbreak’s epicenter, faces additional challenges due to open borders and active gold mining. Local leaders reported no panic among residents but warned that inadequate handwashing stations and understaffed hospitals hinder containment efforts. Dr. Richard Lokudu, medical director of Mongbwalu General Hospital, stated staff lack training to manage suspected cases, and the facility has no protective measures in place. A student from the local medical technology institute died on Wednesday, raising concerns about further spread. Experts anticipate the outbreak could last at least two months, with no approved vaccine or medicine available for the Bundibugyo strain. Congo is awaiting shipments of an experimental vaccine from the U.S. and Britain, developed by Oxford researchers. Jean-Jacques Muyembe, a virus expert at the National Institute of Biomedical Research, noted trials will begin to assess its effectiveness. Meanwhile, health officials urge immediate action to install triage and isolation facilities to prevent further transmission.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.